Skip to main content
Log in

Metronidazole for trichomoniasis cost-effective HIV prevention

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Price MA, Stewart SR, Miller WC, Behets F, Dow WH, Martinson FEA, Chilongozi D, Cohen MS.The cost-effectiveness of treating male trichomoniasis to avert HIV transmission in men seeking sexually transmitted disease care in Malawi. JAIDS 43: 202-209, No. 2, 1 Oct 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Metronidazole for trichomoniasis cost-effective HIV prevention. Pharmacoecon. Outcomes News 518, 6 (2006). https://doi.org/10.2165/00151234-200605180-00018

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605180-00018

Keywords

Navigation